Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
May 02, 2026
Xerox Holdings (XRX): +114% Surge in 30 Days – Unpacking the Drivers and Outlook

Xerox Holdings (XRX): +114% Surge in 30 Days – Unpacking the Drivers and Outlook

Key Takeaways

  • Xerox Holdings Corporation (XRX) stock price surged +114% over the past 30 days, driven primarily by a strong Q1 2026 revenue beat from the Lexmark acquisition.
  • Over the past quarter, XRX is up +17%, recovering from mid-period lows amid volatile trading and financial concerns.
  • Key catalysts include Q1 earnings release showing 27% revenue growth, cost-saving measures improving margins, and acquisition integration benefits.
  • Earlier quarterly weakness stemmed from pro forma revenue declines and a credit rating downgrade by Moody's on financial performance worries.
  • High trading volume post-earnings signals shifting market sentiment toward optimism on strategic shifts.

Xerox Holdings (XRX) Company Overview and Market Position

Xerox Holdings Corporation (XRX) is a workplace technology company specializing in document management solutions, including hardware, software, and services for printing and digital workflows. Its core business model focuses on selling print and digital document technologies, managed print services, and outsourcing to enterprises worldwide. Operating in the competitive document technology industry, XRX faces rivals like HP Inc. and Canon but differentiates through integrated solutions and recent expansions via acquisitions. In my view, strong fundamentals in recurring service revenue and cost discipline have supported the recent price recovery, while exposure to enterprise spending and acquisition synergies explain the sharp rebound amid prior operational challenges.

XRX Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, XRX stock rose from approximately $1.26 to $2.70, marking a +114% gain. The movement was highly volatile and trend-driven, with a massive spike following the Q1 earnings release, including a 43% single-day jump on April 30 and further gains the next session amid elevated volume exceeding 60 million shares. I also checked this using Tickeron’s AI Trend Prediction Engine to confirm the momentum shift.

For the past quarter, the stock climbed +17% from around $2.30 to $2.70. Performance was range-bound and choppy, declining steadily to a low near $1.26 in early April before the sharp post-earnings reversal. Overall, it exhibited high volatility with multiple swings reflecting company-specific news flows.

What Drove XRX Stock Price in the Last 30 Days

The primary catalyst for XRX's dramatic 30-day rally was the Q1 2026 earnings report released on April 30, which showed revenue of $1.85 billion, up 27% year-over-year (24% in constant currency), beating analyst expectations. This growth was fueled by the recent Lexmark acquisition, boosting equipment sales and overall topline. Although adjusted EPS of -$0.43 missed estimates of -$0.27 (earnings per share), investors focused on revenue strength, margin expansion from cost savings, and pro forma guidance signals. Shares exploded 43% that day on massive volume, followed by another 20% gain, reflecting positive sentiment shift. No major analyst upgrades were noted, but market reaction underscored optimism around acquisition synergies in a challenged document sector. One thing that stands out to me is how the volume surge validated this turn.

What Drove XRX Stock Performance Over the Last Quarter

XRX's quarterly performance reflected a down-then-up pattern amid broader operational headwinds. Early in the period, shares declined over 45% from February highs near $2.30 to April lows around $1.26, pressured by ongoing pro forma revenue softness (down 4% in Q1) and a Moody's downgrade citing financial performance concerns. Institutional selling and weak sentiment in the printing industry, tied to digital shifts and enterprise cost-cutting, amplified the drop. The late-quarter surge on Lexmark-driven earnings reversed the trend, with cost discipline aiding adjusted margins. Cumulative impact stemmed from acquisition progress outweighing macro demand pressures and prior structural issues in legacy print business. I’m watching this closely to see if the recovery holds.

Trending AI Robots

One tool I rely on regularly for insights is Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI-powered trading bots from a library of hundreds that analyze and trade thousands of stock tickers across various markets. These curated bots are selected based on recent performance metrics, relevance to current market trends, and consistency in strategies like trend-following, mean reversion, or momentum plays. Each bot displays key stats such as win rate, average return, Sharpe ratio (a measure of risk-adjusted performance), and applicable timeframes from intraday to long-term. From my experience reviewing detailed backtests and live results, traders can customize these to fit their risk tolerance and enhance stock analysis with data-driven automation.

XRX Stock Forecast Drivers: What Investors Should Watch Next

Investors in XRX should monitor progress on Lexmark integration, including revenue synergies and cost savings realization. Upcoming Q2 earnings will provide updates on pro forma trends and guidance amid document sector dynamics. Watch macroeconomic factors like interest rates affecting enterprise IT spending, potential regulatory scrutiny on M&A (mergers and acquisitions), and shifts in print demand versus digital alternatives. Analyst revisions post-Q1, institutional ownership changes, and competitive moves in workplace tech could sway sentiment. Key risks include execution delays or persistent EPS pressure, while catalysts may arise from new product launches or margin improvements. This is important because it will shape whether the rally sustains.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: XRX

XRX's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Oscillator for XRX moved out of overbought territory on July 31, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 instances where the indicator moved out of the overbought zone. In of the 28 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

XRX moved below its 50-day moving average on July 31, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for XRX crossed bearishly below the 50-day moving average on July 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XRX broke above its upper Bollinger Band on July 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for XRX entered a downward trend on July 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where XRX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 30, 2026. You may want to consider a long position or call options on XRX as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for XRX just turned positive on July 30, 2026. Looking at past instances where XRX's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XRX advanced for three days, in of 263 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.199) is normal, around the industry mean (0.992). P/E Ratio (0.000) is within average values for comparable stocks, (664.061). Projected Growth (PEG Ratio) (0.152) is also within normal values, averaging (0.480). Dividend Yield (0.034) settles around the average of (0.050) among similar stocks. P/S Ratio (0.049) is also within normal values, averaging (0.788).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

Notable companies

The most notable companies in this group are Xerox Holdings Corp (NASDAQ:XRX).

Industry description

Commercial Printing/Forms industry includes companies that provide printing services, business forms, letterheads, commercial printing and product labels. Some companies in this business are also involved with pre-press operations and desktop publishing. Like many other businesses, the commercial printing industry has also been adopting newer technologies (like advanced digital high-speed inkjet) to up the ante on the modern-day digitally progressive enterprise landscape. Prominent players in this industry include Cimpress N.V., Deluxe Corporation and Ennis, Inc,. to name a few.

Market Cap

The average market capitalization across the Commercial Printing/Forms Industry is 352.48M. The market cap for tickers in the group ranges from 3.25M to 5.46B. BRTHY holds the highest valuation in this group at 5.46B. The lowest valued company is COGV at 3.25M.

High and low price notable news

The average weekly price growth across all stocks in the Commercial Printing/Forms Industry was 3%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 6%. XRX experienced the highest price growth at 14%, while ACTG experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Commercial Printing/Forms Industry was 279%. For the same stocks of the Industry, the average monthly volume growth was -64% and the average quarterly volume growth was 31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 46
Price Growth Rating: 46
SMR Rating: 84
Profit Risk Rating: 86
Seasonality Score: -13 (-100 ... +100)
View a ticker or compare two or three
XRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a devloper of document management systems and solutions

Industry CommercialPrintingForms

Profile
Details
Industry
Computer Peripherals
Address
201 Merritt 7
Phone
+1 203 849-5216
Employees
20100
Web
https://www.xerox.com
Interact to see
Advertisement
FingerMotion, Inc. (NASDAQ: FNGR) reported fiscal third-quarter 2026 results on January 15, 2026, triggering a sharp selloff as investors reacted to a steep revenue decline and widening losses. Shares fell roughly 32% following the release after the mobile services provider disclosed a 32% year-over-year drop in revenue and a net loss of $1.67 million for the quarter ended November 30, 2025.
The SPDR S&P Aerospace & Defense ETF (XAR) has surged to a new 52-week high above $281 this week, climbing 21% month-to-date and 20% year-to-date through January 2026. The rally, driven by robust sector momentum and a clean technical breakout, is outpacing broader indices like the S&P 500. XAR’s equal-weighted structure amplifies gains from top aerospace and defense holdings in missiles, aircraft, and space systems, attracting significant trader and institutional attention amid heightened geopolitical tensions.
Chevron’s upcoming Q4 report highlights its first full quarters integrating Hess, following record Q3 production of 4.1 million barrels of oil equivalent per day (MMboe/d). Comparing CVX with ExxonMobil and Shell provides insight into how each supermajor is navigating a volatile oil market with prices hovering below $60 per barrel.
SoFi Technologies is set to report Q4 and full-year 2025 earnings on January 30, 2026, closing out a pivotal year for the digital finance platform. With its fiscal year ending December 31, the report follows a strong Q3 that featured record net revenue of $962 million and member growth to 12.6 million, a 35% year-over-year increase.
ASML reported Q4 2025 net sales of $9.7 billion, gross margin of 52.2%, net income of $2.8 billion, and record net bookings of $13.2 billion, including $7.4 billion in EUV orders.
IDEXX Laboratories (IDXX) reports Q4 2025 earnings on February 2, 2026, with analysts expecting continued strength in recurring revenue from companion animal diagnostics. Danaher (DHR) reports on January 28, while Thermo Fisher Scientific (TMO) follows in early February, with both facing low-single-digit core growth expectations across life sciences and diagnostics.
NIO Inc. (NIO) produced its one-millionth vehicle this week at its Hefei facility, closing out a record 2025 delivery total of 326,028 units, up 46.9% year over year. The milestone, announced January 6, reflects accelerating demand for core models such as the ES8 SUV and newer brands ONVO and Firefly.
Faraday Future Intelligent Electric Inc. (FFAI) shares traded near $1.02 this week following announcements of a non-binding $10 million stock purchase term sheet with AIxCrypto (AIxC) and preparations for a Stockholders’ Day on January 7, 2026. Trading volume spiked amid broader EV volatility, highlighting investor attention on FFAI’s pivot toward AI-enhanced mobility and robotics.
BTQ Technologies Corp. (BTQ), formerly BTQQF, launched the Bitcoin Quantum testnet this week—the first quantum-safe Bitcoin fork, 17 years after Bitcoin’s genesis block. The move coincided with inclusion in the $524.5 million VanEck Quantum Computing UCITS ETF, boosting European investor visibility.
VEU targets large- and mid-cap ex-U.S. stocks with ~3,800 holdings. VXUS offers broad all-cap exposure, including ~8,600 stocks across small-, mid-, and large-cap companies.
Apple (AAPL) reports Q1 FY2026 earnings on January 29, with consensus revenue at $138.5B and EPS at $2.67, supported by strong demand for iPhone 17 models, higher average selling prices, and continued Services growth. Microsoft (MSFT) reports Q2 FY2026 on January 28, expecting $80.3B revenue and $3.91 EPS, driven by Azure AI adoption and enterprise cloud expansion, though elevated capex spending (~$35B/quarter) remains under scrutiny.
Visa Inc. (V), the global payments network leader, reports Q1 FY2026 earnings on January 29, 2026, for the period ending December 31, 2025. This marks the start of FY2026 following a strong FY2025, where net revenue reached $40 billion (+11%) and EPS climbed to $11.47 (+14%). Investors are watching closely for insights into consumer spending, cross-border travel recovery, and digital payment adoption.
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.